Vestal Point Capital’s SpyGlass Pharma SGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.6M Sell
640,000
-30,000
-4% -$739K 0.43% 31
2026
Q2
$14.9M Buy
670,000
+3,240
+0.5% +$70.3K 0.35% 48
2026
Q1
$17.3M Buy
+666,760
New +$17.9M 0.48% 53

Other funds holding SGP

Vestal Point Capital's SGP Position: Q3 2026 in Review

Vestal Point Capital reduced its SpyGlass Pharma (SGP) stake by 4.5% in Q3 2026, selling an estimated $739K and leaving 640,000 shares worth $16.6M. The position accounts for 0.43% of the portfolio, ranked #31.

Vestal Point Capital first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. The position peaked at $17.3M in Q1 2026. 70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

  • Vestal Point Capital held 640,000 shares of SpyGlass Pharma worth $16.6M as of Q3 2026.
  • Vestal Point Capital sold 30,000 SpyGlass Pharma shares in Q3 2026, an estimated $739K.
  • SpyGlass Pharma made up 0.43% of Vestal Point Capital's portfolio in Q3 2026, its #31 holding.
  • Vestal Point Capital first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
  • Vestal Point Capital's SpyGlass Pharma position peaked at $17.3M in Q1 2026.
  • 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Vestal Point Capital's 13F filing for Q3 2026, filed 16 Nov 2026.